Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120

被引:17
|
作者
Kirchherr, Jennifer L. [1 ,2 ]
Hamilton, Jennifer [1 ,2 ]
Lu, Xiaozhi [1 ,2 ]
Gnanakaran, S. [4 ]
Muldoon, Mark [5 ]
Daniels, Marcus [4 ]
Kasongo, Webster [6 ]
Chalwe, Victor [6 ]
Mulenga, Chanda [6 ]
Mwananyanda, Lawrence [6 ]
Musonda, Rosemary M. [6 ]
Yuan, Xing [3 ]
Montefiori, David C. [3 ]
Korber, Bette T. [4 ,7 ]
Haynes, Barton F. [1 ,2 ]
Gao, Feng [1 ,2 ]
机构
[1] Duke Univ, Duke Human Vaccine Inst, Med Ctr, Durham, NC 27710 USA
[2] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA
[3] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA
[4] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[5] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England
[6] Trop Dis Res Ctr, Ndola, Zambia
[7] Santa Fe Inst, Santa Fe, NM 87501 USA
基金
美国国家卫生研究院;
关键词
HIV-1; Envelope; Genetic variation; Neutralization; Signature; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; ENV CLONES; POINT MUTATIONS; HIV-1; VACCINE; GP41; TRANSMISSION; INFECTION;
D O I
10.1016/j.virol.2010.09.031
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Neutralizing antibodies (Nabs) are thought to play an important role in prevention and control of HIV-1 infection and should be targeted by an AIDS vaccine. It is critical to understand how HIV-1 induces Nabs by analyzing viral sequences in both tested viruses and sera. Neutralization susceptibility to antibodies in autologous and heterologous plasma was determined for multiple Envs (3-6) from each of 15 subtype-C-infected individuals. Heterologous neutralization was divided into two distinct groups: plasma with strong, cross-reactive neutralization (n=9) and plasma with weak neutralization (n=6). Plasma with cross-reactive heterologous Nabs also more potently neutralized contemporaneous autologous viruses. Analysis of Env sequences in plasma from both groups revealed a three-amino-acid substitution pattern in the V4 region that was associated with greater neutralization potency and breadth. Identification of such potential neutralization signatures may have important implications for the development of HIV-1 vaccines capable of inducing Nabs to subtype C HIV-1. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [31] Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm
    Brogi, A
    Presentini, R
    Solazzo, D
    Piomboni, P
    ConstantinoCeccarini, E
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (06) : 483 - 489
  • [32] Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization
    Suphaphiphat, P
    Thitithanyanont, A
    Paca-Uccaralertkun, S
    Essex, M
    Lee, TH
    JOURNAL OF VIROLOGY, 2003, 77 (06) : 3832 - 3837
  • [33] DIFFERENTIAL REGULATION OF CELLULAR TROPISM AND SENSITIVITY TO SOLUBLE CD4 NEUTRALIZATION BY THE ENVELOPE GP120 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    STAMATATOS, L
    WERNER, A
    CHENGMAYER, C
    JOURNAL OF VIROLOGY, 1994, 68 (08) : 4973 - 4979
  • [34] Gp120 in the Pathogenesis of Human Immunodeficiency Virus-Associated Pain
    Yuan, Su-Bo
    Shi, Yuqiang
    Chen, Jinghong
    Zhou, Xiangfu
    Li, Guangyu
    Gelman, Benjamin B.
    Lisinicchia, Joshua G.
    Carlton, Susan M.
    Ferguson, Monique R.
    Tan, Alai
    Sarna, Sushil K.
    Tang, Shao-Jun
    ANNALS OF NEUROLOGY, 2014, 75 (06) : 837 - 850
  • [35] Immunologic mechanism for human immunodeficiency virus type 1 gp120 vaccine failure
    OToole, C
    Muller, S
    Nara, P
    Kohler, H
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02): : 512 - 513
  • [36] Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes
    D. Galey
    K. Becker
    N. Haughey
    A. Kalehua
    D. Taub
    J. Woodward
    M. P. Mattson
    A. Nath
    Journal of NeuroVirology, 2003, 9 : 358 - 371
  • [37] Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes
    Galey, D
    Becker, K
    Haughey, N
    Kalehua, A
    Taub, D
    Woodward, J
    Mattson, MP
    Nath, A
    JOURNAL OF NEUROVIROLOGY, 2003, 9 (03) : 358 - 371
  • [38] Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes
    Yamaguchi-Kabata, Y
    Gojobori, T
    JOURNAL OF VIROLOGY, 2000, 74 (09) : 4335 - 4350
  • [39] Inter- and intra-subtype neutralization of human immunodeficiency virus type-1
    Bradac, J
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 87 - 95
  • [40] Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41
    Matsuda, S
    Noda, M
    MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (11) : 923 - 929